Atlas Trials

iPSC-based Drug Repurposing for ALS Medicine (iDReAM) Study

Clinical trial NCT04744532 · COMPLETED

Trial details

NCT number
NCT04744532
Sponsor
Kyoto University
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Amyotrophic Lateral Sclerosis
Start date
2019-03-19
Primary completion
2024-01-16
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.